Proskauer advised Flagship Pioneering on the transaction.
Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the closing of Fund VII.
The fund closed with a total capital pool of approximately $3.4 billion, which includes the recent $2.2 billion capital expansion raised from current Flagship investors and a select group of new investors.
Fund VII will continue to invest in and grow its next generation of human health and sustainability bioplatform companies originated within the Flagship Labs unit of Flagship Pioneering.
The Proskauer team was led by partner, Howard Beber (Picture), funds counsel Louis Sorgi, and associates Alex Martin, Carol Sullivan and Rachel McKie (Private Funds); partners Arnold May and Stephen Severo, and associate Charles McGonigal (Tax); and senior counsel Adam Scoll (ERISA).
Involved fees earner: Howard Beber – Proskauer Rose; Alexandria Martin – Proskauer Rose; Arnold May – Proskauer Rose; Charles McGonigal – Proskauer Rose; Rachel McKie – Proskauer Rose; Adam Scoll – Proskauer Rose; Stephen Severo – Proskauer Rose; Louis Sorgi – Proskauer Rose; Carol Sullivan – Proskauer Rose;
Law Firms: Proskauer Rose;
Clients: Flagship Pioneering;